Additionally, IDH1/2 mutations are more frequent in the SIAD MDS cohort (14% vs. 4%, p < 0.01), with a higher VAF being observed in SIAD patients (38% vs. 26%, p = 0.04). The gene discussed is IDH1; the disease is myelodysplastic syndrome.